…a new quality guarantee for training providers in France.
The quality certification has been issued for the following category of action TRAINING ACTIVITIES.
This certification complies with the law of 5 September 2018 “for the freedom to choose one’s professional future”, which imposes mandatory certification according to a single national reference system. Training is a major stake for the quality assurance policies, particularly in the highly regulated sector of clinical research. It is also a key factor in maximising productivity. We provide an expert team to guide and train you.
Download our Qualiopi Certificate
to be independent in designing and configure an eCRF and/or in configuring the related administrative environment. These training courses firstly target data managers and project managers.
enables investigators, CRAs (Clinical Research Assistants), CSTs (Clinical Studies Technicians), etc., to use the software features in an autonomous way.
This training activity is registered under number 11 92 19676 92. It is part of continuous training actions according to the articles L 6313-1 to L 6313-11 of the French Employment Code. It provides financial assistance in the name of continuous professional training.
Number of training certificates issued :
191
Number of training
days completed :
29days
Overall trainee satisfaction rate :
100%
If you have any questions about our training program, please do not hesitate to contact our dedicated department by email at
formation-cleanweb@tentelemed.com
Download our rules of procedure
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
February 29, 2024
4 and 5 march 2024 TELEMEDICINE TECHNOLOGIES is delighted to announce its participation in the upcoming ACDM24 conference, the largest European event in clinical data management for 2024! Join us in Copenhagen from March 3rd to 5th, where industry leaders and experts will gather to explore the latest trends in the field. Christophe Golenvaux and […]
February 29, 2024
Bio Pharm International FDA’s Drug Safety Priorities FY23 describes the center’s key safety programs and activities involved in promoting and protecting public health. On Feb. 15, 2024, FDA’s Center for Drug Evaluation and Research (CDER) released its report, Drug Safety Priorities FY23. The report describes the center’s key safety programs and activities involved in promoting and […]
February 29, 2024
Fierce Biotech In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, multidisciplinary, and cost-effective approaches. Pathways have become a critical strategy for both physicians and payers to streamline treatment decision-making, standardize evidence-based care, improve patient outcomes […]